HOT :  Venetian Gondola Boat , Macau Tower , Galaxy 3 In 1 Package

SINGAPORE, March 16, 2016 /PRNewswire/ -- With growing populations and increasingly higher global healthcare standards, the biopharma landscape in Asia is changing. How can we cope with these changes, and what do we need to be prepared for as we move towards 2020?

AstraZeneca and ASLAN Pharmaceuticals will lead a keynote panel discussion on the opening day of Biopharma Asia Convention conference and expo taking place at Suntec Singapore on 23 March 2016.

Leading the panel discussion will be Ajay Gautam, Executive Director and Head, Asia Pacific and Emerging Markets, Scientific Partnering and Alliances at AstraZeneca China and Carl Firth, Chief Executive Officer of ASLAN Pharmaceuticals in Singapore. The panel will be moderated by Yariv Hefez, VP Strategic Development, Business Development, Portfolio Management and Partnering (Biosimilar), Merck, Switzerland.

On Day 2 of the conference (24 March 2016), Deputy Director of the Singapore Economic Development Board, Ms Weng Si Ho will keynote the conference with the topic: Creating an international Biomedical Sciences hub: Lessons learned and successes achieved. Following several years of enhanced investment in developing a biomedical sciences hub, how can we measure its success? Using Singapore as the case study, she will provide an insight into the challenges faced in establishing Singapore as a key biomedical sciences hub, the successes achieved so far and plans for the future.

Speakers at the 2016 edition of Biopharma Asia Convention come from Asia Pacific and globally. They include:

  • Silviu Itescu, CEO & Managing Director, Mesoblast
  • Dr Satish Jindal, Chief Executive Officer, Allied-Bristol Life Sciences (ABLS)
  • Dr Arun Maseeh, Vice President, Medical Affairs, Cadila Pharmaceuticals
  • Mr Niven R. Narain, Co-Founder, President and Chief Technology Officer, Berg Pharma
  • Dr Jun Wang, Board Member, iCarbonX
  • Dr Hugh Davis, Vice President, Head of Biologics Clinical Pharmacology and China Biologics Leader, Janssen BioTherapeutics
  • Mr Sean Cao, Vice President, Global Business Development, Simcere Pharmaceutical Group
  • Dr Steven Lee, Global Head, Biologics Technical Operations, Dr. Reddy's Laboratories Ltd.
  • Dr Raman Srinivasan, Vice President and Head of Operations, Biocon Limited
  • Dr GS Reddy, Chief General Manager, Manufacturing, Indian Immunologicals Ltd
  • Mr Richard West, Director, Behcet's International
  • Beverley Yamamoto, President Professor, Herediatary Angioedema Japan (HAEJ); Osaka University
  • Dr Rachel Yang, International Relation, Chinese Organization for Rare Disorders
  • Bill Claxton, Director, Asia Pacific Alliance of Rare Disease Organisation
  • Dr Badri Rengarajan, Former President, The International Pemphigus And Pemphigoid Foundation
  • Dr Bertil Lindmark, Chief Scientific Officer, ASLAN Pharmaceuticals
  • Prof Zelig Eshhar, PhD, Chair of Immunology, Tel Aviv Surasky Medical Center
  • Dr Nick Ede, Chief Technology Officer, Imugene Ltd
  • Mr Peter Hoang, Senior Vice President of Business Development and Strategy, Bellicum Pharmaceuticals
  • Dr Nikhil Singla, Associate Director, Vaccine R&D Program, International AIDS Vaccine Initiative (IAVI)
  • Dr Pauline Yeo, Head, Regulatory Affairs and Quality Assurance, D3 (Drug Discovery & Development), A*STAR

The conference is expected to attract over 600 attendees with focused streams on partnering, pricing and policies, clinical trials, supply chain, manufacturing, vaccine, orphan drugs, biosimilars and antibodies.

5 startup biotechs -- Novogen, Cennerv Pharma, Yisheng Biopharma, Sphaera Pharma, Hummingbird Bioscience -- will also be present to pitch their start-ups to leading investors and pharmas.

Alongside the conference is an exhibition with over 50 exhibitors showcasing products, solutions and services from companies like Merck, Marken, GE Healthcare, Fedex, NiHR (CRN), PRA Healthsciences, Lion Bridge Lifesciences and more. Two on-floor theatres will feature the latest research and technology findings by leading Asian research and academic institutions.

About BioPharma Asia Convention
Date: 23-24 March 2016
Conference opening hours: 09:00 am
Venue: Level 4, Hall 404-406, Suntec Singapore International Convention & Exhibition Centre
Website:  www.terrapinn.com/bioasia

About Terrapinn
Terrapinn is a business media company. Its products are trade exhibitions, conferences, training solutions and electronic and print publications. For more information, please visit www.terrapinn.com.

Note: Press registration for the conference is compulsory and advance scheduling for speaker/ sponsor interviews is recommended. Final issuance of press passes is subjected to Terrapinn's discretion.  For your press pass, please contact the following:

Lydia Sebastian
Tel: +65 6322 2750
lydia.sebastian@terrapinn.com 

 

SALE :  SKY100  ,   Madame Tussauds  ,  HK 3D Museun ;

News Sources
About PR Newswire
PR Newswire is the premier global provider of news release distribution and multimedia platforms that enable marketers, public relations officers and investor relations professionals to engage with their key audiences: businesses and consumers, the media, and investors.